Cochrane · systematic review · CD012637
Oral paracetamol (acetaminophen) for cancer pain
Wiffen, PJ, Derry, S, Moore, RA, et al. · Cochrane Database of Systematic Reviews · 2017 · Cochrane Library
Pain, Palliative and Supportive CareAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
8
current version
GRADE rated
8
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 8 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Comparison
Population: people with cancer pain
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Participants with at least 30% or at least 50% reduction in pain | no estimate extracted | NR | Very low |
PGIC much or very much improved | no estimate extracted | NR | Very low |
Mean pain intensity at end of study | no estimate extracted | 3 studies · 93 participants | Very low |
Pain no worse than mild at one or two weeks (or equivalent) | no estimate extracted | NR | Very low |
Mean quality of life or "well‐being" | no estimate extracted | 3 studies · 93 participants | Very low |
Participant preference | no estimate extracted | 2 studies · 52 participants | Very low |
Adverse events | no estimate extracted | 2 studies · 80 participants | Very low |
Serious adverse events | no estimate extracted | 3 studies · 93 participants | Very low |